Targeting the brain changes that cause depression in Parkinson's
Official title: Identifying and targeting the neural basis of depression in Parkinson's disease
Funded at Yale University · NIH-11308687 · Data updated 2026-11-12
Using brain PET and MRI scans, researchers will look for specific synapse and network changes linked to depression in people with Parkinson's and try treatments aimed at those changes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | April 1, 2024 |
| Project end | March 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $623,499 |
| NIH project number | 5R01NS125482-03 |
| Project ID | NIH-11308687 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with Parkinson's disease who are currently experiencing depressive symptoms and can safely undergo PET and MRI scans are ideal candidates.
✕Less likely to help
People without Parkinson's, those with severe cognitive impairment, or anyone who cannot have PET/MRI scans (for example due to implanted devices or pregnancy) may not directly benefit from participation.
What this research studies
If you join, you would get a PET scan that measures synaptic density and an fMRI that shows how brain areas connect. The team will compare people with Parkinson's and depression, people with Parkinson's without depression, people with major depression, and healthy volunteers to find what is unique to depression in Parkinson's. These imaging findings will point to specific brain circuits and synaptic losses that could be targeted by new treatments. The goal is to move from imaging discoveries to interventions that better treat depression in Parkinson's.
Why it matters
Potential benefit: Could lead to targeted treatments that relieve depression in Parkinson's and possibly slow related worsening of function.
How similar studies have gone: Prior imaging work has shown lower synaptic density in Parkinson's and links to depression, but combining PET and fMRI to find unique targets for depression in Parkinson's is a relatively new approach.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Holmes, Sophie — Yale University
- Study coordinator: Holmes, Sophie
Related research
Other NIH-funded projects on the same topics.
-
Brain circuit activity in Parkinson's linked to depression
This project looks for specific brain signals in people with Parkinson's that relate to depression and that might show who could get mood benefit from deep brain stimulation.
-
Investigating how brain activity in the basal ganglia relates to depression in Parkinson's disease
This study is looking at how depression affects the brains of people with Parkinson's disease to find better ways to help them feel better, especially through a treatment called deep brain stimulation.
-
Exploring the brain mechanisms of depression in Parkinson's disease
This study is looking at how depression affects the brains of people with Parkinson's disease to find out what’s happening in their brains and help create better treatments for them.
-
Investigating how ketamine affects depression and brain changes in Veterans with Parkinson's disease
This study is looking at how ketamine might help improve mood and brain flexibility in Veterans with Parkinson's disease who are dealing with depression, and it aims to find better ways to treat their symptoms.
-
Gut-brain clues in Parkinson’s disease: supplement to a large registry
A plant-wide supplement to an NIH program will enroll people with Parkinson’s, with and without GI symptoms, plus healthy controls, to study how gut function, brain signals, and sleep rhythms relate to Parkinson’s symptoms.
-
Gut-brain connections in Parkinson’s disease: how the gut and environment shape symptoms
A Mayo Clinic team is studying how gut problems, environmental factors, and genetics together influence Parkinson’s disease and its GI symptoms to find biomarkers and better understanding of the disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.